← 產業報告目錄

Agriculture Biotechnology Market by Type of Organism (Plant, Animal, and Microbes), by Type, by Technology, and by Application - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Agriculture出版日期 2025-10-31頁數 507報告編號 AGI9584

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The agriculture biotechnology market is estimated at USD 92.19 billion in 2025 and is projected to reach USD 144.25 billion by 2030, at a CAGR of 9.4%. The growth of the agriculture biotechnology market is mainly driven by increasing global food demand, diminishing arable land, and the need for sustainable farming solutions. Biotechnology provides advanced methods to increase crop yields, improve soil health, and boost livestock productivity while reducing environmental impact. The rising use of genetically modified (GM) crops, microbial inoculants, and biofertilizers supports better resource management and less reliance on chemicals. Moreover, climate change pressures have sped up the adoption of drought-tolerant and pest-resistant crop varieties, ensuring greater resilience in farming. Governments and international groups are encouraging biotech innovations through supportive regulations, research funding, and sustainability efforts. Additionally, quick progress in genome editing, molecular diagnostics, and microbial engineering is broadening the use of agricultural biotechnology in plant, animal, and microbial systems. Collectively, these factors are driving a shift toward high-tech, eco-friendly, and high-yield agriculture worldwide. “Plant biotechnology is projected to dominate the market during the forecast period.” The plant biotechnology segment is expected to dominate the global agriculture biotechnology market during the forecast period. This leadership is due to widespread adoption of genetically modified (GM) crops, advancements in seed trait development, and increased use of biofertilizers and biopesticides. Rising global food demand, combined with the need for higher crop yields with limited natural resources, is fueling the adoption of plant biotechnology solutions. Farmers are increasingly opting for GM varieties that offer herbicide tolerance, pest resistance, and improved stress tolerance to achieve better yields and profits. Additionally, innovations in CRISPR and molecular breeding technologies are enhancing precision in crop improvement, enabling faster commercialization of new varieties. Supportive government policies promoting sustainable agriculture, along with public-private R&D investments, are further reinforcing this segment’s position. The growing need for climate-resilient and nutrient-rich crops will continue to make plant biotechnology a key driver of innovation in modern agriculture throughout the forecast period. “The genetic engineering and genome editing subsegment is projected to dominate the agriculture biotechnology market during the forecast period.” The genetic engineering and genome editing segment is expected to lead the agriculture biotechnology market during the forecast period due to its transformative effect on crop and livestock improvement. Technologies like CRISPR-Cas9, TALEN, and RNA interference (RNAi) are allowing scientists to create precise, high-yield varieties with better yield, stress tolerance, and nutritional content. An example is Calyxt’s gene-edited soybean, which produces healthier high-oleic oil and was among the first CRISPR-based crops to be commercialized in the US. Likewise, Corteva Agriscience has developed drought-tolerant maize using advanced gene-editing methods, greatly enhancing resilience in water-scarce areas. In livestock, Genus PLC has developed pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS), a breakthrough that enhances animal welfare and cuts economic losses. Governments in Brazil, the US, and Argentina have also relaxed regulations on gene-edited crops, supporting faster commercialization. Supported by strong R&D investments, global partnerships, and evolving biosafety frameworks, genetic engineering and genome editing are set to remain the leading technologies that drive efficiency, sustainability, and innovation in agricultural biotechnology through 2030. “Asia Pacific is projected to be the fastest-growing market during the forecast period.” The Asia Pacific region is expected to see the fastest growth in the agriculture biotechnology market during the forecast period, fueled by increasing food demands, expanding agricultural modernization, and government-supported initiatives that promote sustainable farming practices. Countries like China, India, Japan, and the Philippines are increasingly investing in biotechnology R&D to improve crop yields, livestock health, and soil fertility. The rising adoption of genetically modified (GM) crops, microbial biofertilizers, and bio-based pest control products is transforming the region’s agricultural landscape. India’s approval of GM mustard (Dhara Mustard Hybrid-11) in 2023 and China’s increasing commercialization of gene-edited soybean and maize varieties highlight the region’s progressive regulatory approach. Additionally, strong support from regional organizations and public-private partnerships is driving innovation in genome editing, fermentation technologies, and microbial applications. With rapid population growth, limited arable land, and growing focus on food security, the Asia Pacific region is expected to remain the most dynamic and opportunity-rich area in the agriculture biotechnology market through 2030. In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations in the agriculture biotechnology market. • By Company Type: Tier 1–25%, Tier 2–45%, and Tier 3–30% • By Designation: CXOs–20%, Managers–50%, Executives–30% • By Region: North America–25%, Europe–20%, Asia Pacific–30%, South America–15%, and Rest of the World–10% Prominent companies in the market include Bayer Crop Science, Corteva Agriscience, BASF SE, Syngenta AG, Zoetis Inc., Elanco Animal Health, and Novonesis (Novozymes and Chr. Hansen) Research Coverage This research report categorizes the agriculture biotechnology market by organism type (plants, animals, microbes), type (genetic modification, crop protection, soil enhancement, stress tolerance, transgenic animals, vaccines, feed additives, diagnostics, biofertilizers, biocontrol agents, microbial enzymes & biostimulants, microbial genomics & fermentation), technology (genetic engineering, molecular diagnostics, tissue culture, CRISPR, fermentation, metagenomics, synthetic biology, and molecular marker-assisted selection), application (crop protection, yield enhancement, disease resistance, animal health management, soil health improvement, and sustainable nutrient cycling), end user (farmers and producer groups, agribusinesses, seed and input companies, research institutions, and government agencies), and region (North America, Europe, Asia Pacific, South America, the Middle East, and Africa). The report’s scope includes detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of agricultural biotechnology. A comprehensive analysis of key industry players offers insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers and acquisitions, and recent developments in the agriculture biotechnology market. This report also features a competitive analysis of emerging startups within the agriculture biotechnology ecosystem. Additionally, the study covers industry-specific trends such as technology analysis, ecosystem and market mapping, and patent and regulatory landscapes, among other topics. Reasons to Buy This Report The report will provide market leaders and new entrants with approximate revenue figures for the overall agriculture biotechnology sector and its subsegments. It will also help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market pulse and offers information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following points. • Analysis of key drivers (growing demand for sustainable and high-yield biotechnology-based agriculture), restraints (high regulatory hurdles and lengthy approval processes for GMOs), opportunities (increasing adoption of microbial and bio-based agricultural inputs globally), and challenges (public skepticism and ethical concerns over genetic modification technologies) influencing the growth of the agriculture biotechnology market • Product Development/Innovation: Detailed insights into ongoing R&D initiatives in genome editing, CRISPR applications, microbial biofertilizers, and biocontrol agents are included, along with emerging product launches across plant, animal, and microbial biotechnology segments. • Market Development: The report offers comprehensive information about expanding market opportunities across developed and emerging regions, emphasizing growing investment in biotechnology-enabled agriculture. • Market Diversification: Includes detailed analysis of new product innovations, regional adoption patterns, government-funded biotechnology initiatives, and expansion of key players into new applications such as climate-resilient crops and animal health solutions. • Competitive Assessment: In-depth assessment of market share, company strategies, product portfolios, and innovation footprints of leading players such as Bayer AG (Germany), Corteva Agriscience (US), BASF SE (Germany), Syngenta AG (Switzerland), Novonesis (Denmark), Ginkgo Bioworks (US), Zoetis Inc. (US), and ADM Animal Nutrition (US), among others in the agriculture biotechnology ecosystem.
目錄 Table of Contents
1 INTRODUCTION 46 1.1 STUDY OBJECTIVES 46 1.2 MARKET DEFINITION 46 1.3 STUDY SCOPE 47 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 47 1.3.2 INCLUSIONS AND EXCLUSIONS 48 1.3.3 YEARS CONSIDERED 49 1.4 UNITS CONSIDERED 49 1.4.1 CURRENCY CONSIDERED 49 1.5 STAKEHOLDERS 50 2 RESEARCH METHODOLOGY 52 2.1 RESEARCH DATA 52 2.1.1 SECONDARY DATA 53 2.1.1.1 Key data from secondary sources 53 2.1.2 PRIMARY DATA 53 2.1.2.1 Key data from primary sources 54 2.1.2.2 Key primary participants 54 2.1.2.2.1 AGRICULTURE BIOTECHNOLOGY COMPANIES 54 2.1.2.3 Breakdown of primary interviews 55 2.1.2.4 Key industry insights 55 2.2 MARKET SIZE ESTIMATION 56 2.2.1 BOTTOM-UP APPROACH 57 2.2.2 TOP-DOWN APPROACH 58 2.3 DATA TRIANGULATION 61 2.4 FACTOR ANALYSIS 62 2.5 RESEARCH ASSUMPTIONS 63 2.6 RESEARCH LIMITATIONS 64 3 EXECUTIVE SUMMARY 65 4 PREMIUM INSIGHTS 71 4.1 AGRICULTURE BIOTECHNOLOGY MARKET OVERVIEW 71 4.2 AGRICULTURE BIOTECHNOLOGY MARKET: GROWTH RATES OF MAJOR REGIONAL SUBMARKETS 72 4.3 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET FOR PLANT BIOTECHNOLOGY, BY TYPE AND COUNTRY 73 4.4 AGRICULTURE BIOTECHNOLOGY MARKET, BY ORGANISM TYPE AND REGION 74 4.5 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY 75 4.6 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION 75 4.7 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION 76 5 MARKET OVERVIEW 77 5.1 INTRODUCTION 77 5.2 MARKET DYNAMICS 77 5.2.1 DRIVERS 78 5.2.1.1 Growing Need for Sustainable Food Production 78 5.2.1.2 Government Support and Regulatory Approvals 79 5.2.1.3 Rising Focus on Reducing Chemical Inputs 79 5.2.2 RESTRAINTS 79 5.2.2.1 Public Perception and Ethical Concerns 79 5.2.2.2 Infrastructure and Cold Chain Limitations 80 5.2.3 OPPORTUNITIES 80 5.2.3.1 Expansion in Emerging Economies 80 5.2.3.2 Focus on Carbon-negative and Regenerative Agriculture 81 5.2.3.3 Growth in Microbial and Bio-based Inputs 81 5.2.4 CHALLENGES 82 5.2.4.1 Regulatory Uncertainty and Trade Barriers 82 5.2.4.2 Dominance of Few Multinational Players 82 5.2.4.3 Climate and Disease Variability 82 5.3 IMPACT OF GEN AI ON AGRICULTURE BIOTECHNOLOGY 83 5.3.1 INTRODUCTION 83 5.3.2 USE OF GEN AI IN AGRICULTURE BIOTECHNOLOGY 84 5.3.3 CASE STUDY ANALYSIS 85 5.3.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery 85 5.3.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation 85 5.3.4 IMPACT ON AGRICULTURE BIOTECHNOLOGY MARKET 86 5.3.5 ADJACENT ECOSYSTEM WORKING ON GEN AI 86 6 INDUSTRY TRENDS 87 6.1 INTRODUCTION 87 6.2 PORTER’S FIVE FORCES ANALYSIS 87 6.2.1 INTENSITY OF COMPETITIVE RIVALRY 88 6.2.2 BARGAINING POWER OF SUPPLIERS 88 6.2.3 BARGAINING POWER OF BUYERS 89 6.2.4 THREAT OF SUBSTITUTES 89 6.2.5 THREAT OF NEW ENTRANTS 89   6.3 MACROECONOMIC INDICATORS 89 6.3.1 GLOBAL POPULATION GROWTH & FOOD DEMAND 89 6.3.2 STABLE GLOBAL GDP GROWTH AND MACRO PROJECTIONS 90 6.4 SUPPLY CHAIN ANALYSIS 91 6.5 VALUE CHAIN ANALYSIS 92 6.6 ECOSYSTEM ANALYSIS 93 6.6.1 DEMAND SIDE 94 6.6.2 SUPPLY SIDE 94 6.7 INDICATIVE PRICING ANALYSIS 94 6.7.1 INDICATIVE PRICING ANALYSIS, BY KEY COMPANY AND ORGANISM 95 6.7.2 INDICATIVE PRICING BY REGION 97 6.8 TRADE ANALYSIS 99 6.8.1 TRADE ANALYSIS OF HS CODE 843280: PREPARED CULTURE MEDIA FOR DEVELOPMENT OR MAINTENANCE OF MICROORGANISMS, INCLUDING VIRUSES AND THE LIKE, OR OF PLANT, HUMAN, OR ANIMAL CELLS 99 6.8.1.1 Export Trends of Agriculture Biotechnology under HS Code 382100 (2020–2024) 99 6.8.1.2 Import Trends of Agriculture Biotechnology under HS Code 382100 (2020–2024) 100 6.9 KEY CONFERENCES & EVENTS 103 6.10 TRENDS IMPACTING CUSTOMERS’ BUSINESSES 104 6.11 INVESTMENT AND FUNDING SCENARIO 105 6.12 CASE STUDY ANALYSIS 106 6.12.1 PIVOT BIO’S GENE-EDITED NITROGEN-FIXING MICROBES (2025) 106 6.12.2 NOVONESIS MICROBIAL SEED INOCULANT (JUMPSTART®) (2024) 106 6.12.3 RECOMBINETICS — GENE-EDITED LIVESTOCK FOR DISEASE RESISTANCE AND WELFARE ENHANCEMENT (2024) 107 6.13 IMPACT OF 2025 US TARIFF - AGRICULTURE BIOTECHNOLOGY MARKET 107 6.13.1 INTRODUCTION 107 6.13.2 KEY TARIFF RATES 108 6.13.3 PRICE IMPACT ANALYSIS 108 6.13.4 IMPACT ON COUNTRY/REGION 110 6.13.4.1 United States 110 6.13.4.2 European Union 110 6.13.4.3 China 110 6.13.5 IMPACT ON END-USE INDUSTRIES 110 7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 111 7.1 INTRODUCTION 111 7.2 DECISION-MAKING PROCESS 111 7.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 112 7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 112 7.3.2 BUYING CRITERIA 113 7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 114 7.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 114 7.6 MARKET PROFITABILITY 115 8 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 116 8.1 INTRODUCTION 116 8.2 KEY EMERGING TECHNOLOGIES 116 8.3 COMPLEMENTARY TECHNOLOGIES 117 8.4 TECHNOLOGY/PRODUCT ROADMAP 118 8.5 PATENT ANALYSIS 118 8.5.1 LIST OF MAJOR PATENTS 120 8.6 FUTURE APPLICATIONS 124 8.7 IMPACT OF AI/GEN AI ON AGRICULTURE BIOTECHNOLOGY MARKET 124 8.7.1 TOP USE CASES AND MARKET POTENTIAL 125 8.7.1.1 AI Use Cases in Agriculture Biotechnology Market 125 8.7.1.1.1 AI-driven Genomic Selection and Trait Discovery 125 8.7.1.1.2 Precision Bio-input Design and Microbial Optimization 125 8.7.1.1.3 Market Potential Impact of AI in Agricultural Biotechnology 125 8.7.1.1.4 Acceleration of R&D and Commercialization Pipelines 125 8.7.1.1.5 Enabling Data-driven Sustainable Agriculture and Global Scalability 126 8.7.2 BEST PRACTICES IN AGRICULTURE BIOTECHNOLOGY PROCESSING 126 8.7.3 CASE STUDIES OF AI IMPLEMENTATION IN AGRICULTURE BIOTECHNOLOGY MARKET 127 8.7.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery 127 8.7.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation 128 8.7.4 INTERCONNECTED & ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 128 8.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN AGRICULTURE BIOTECHNOLOGY MARKET 128 8.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 129 9 SUSTAINABILITY AND REGULATORY LANDSCAPE 130 9.1 INTRODUCTION 130 9.2 REGIONAL REGULATIONS AND COMPLIANCE 130 9.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 130 9.2.2 INDUSTRY STANDARDS 133 9.3 SUSTAINABILITY INITIATIVES 134 9.3.1 CARBON IMPACT AND ECO-APPLICATIONS OF AGRICULTURE BIOTECHNOLOGY 134   9.4 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 134 9.5 CERTIFICATIONS, LABELING, ECO-STANDARDS 135 10 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM 137 10.1 INTRODUCTION 138 10.2 PLANTS 139 10.2.1 GROWING GLOBAL FOOD DEMAND, CLIMATE CHANGE RESILIENCE, AND SUSTAINABILITY GOALS ACCELERATING ADOPTION OF PLANT BIOTECHNOLOGY 139 10.3 ANIMALS 140 10.3.1 RISING PROTEIN DEMAND, DISEASE PREVENTION NEEDS, AND SUSTAINABLE LIVESTOCK PRODUCTION DRIVING ANIMAL BIOTECHNOLOGY ADVANCEMENTS 140 10.4 MICROBIALS 141 10.4.1 RISING DEMAND FOR SUSTAINABLE SOIL HEALTH, BIOFERTILIZERS, AND ECO-FRIENDLY PEST CONTROL DRIVES MICROBIAL BIOTECHNOLOGY GROWTH 141 11 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE 143 11.1 INTRODUCTION 144 11.2 PLANT BIOTECHNOLOGY MARKET, BY TYPE 144 11.2.1 GROWING FOCUS ON ENHANCING CROP YIELD, STRESS RESISTANCE, AND SUSTAINABILITY 144 11.2.2 GENETIC MODIFICATION 149 11.2.2.1 Crop protection (Biopesticides, Herbicide-tolerant Traits) 149 11.2.2.1.1 Rising pest resistance, yield loss, and sustainability goals drive innovation in biotechnology-based crop protection 149 11.2.2.2 Soil enhancement (Biofertilizers, Microbial Solutions) 150 11.2.2.2.1 Declining soil fertility and sustainable farming practices are driving demand for biotechnology-based soil enhancement solutions 150 11.2.2.3 Stress tolerance (Drought/Heat-resistant Crops) 150 11.2.2.3.1 Climate change, erratic weather, and yield instability are driving demand for stress-tolerant biotechnology crops 150 11.2.2.4 Animal biotechnology market, by type 150 11.2.2.4.1 Focus on improving livestock productivity, health, and genetic performance 150 11.2.3 TRANSGENIC ANIMALS 152 11.2.3.1 Animal vaccine development 152 11.2.3.1.1 Increasing livestock diseases and zoonotic threats drive demand for advanced biotechnology-based animal vaccine solutions 152 11.2.3.2 Feed additives & nutrient optimization 153 11.2.3.2.1 Rising demand for efficient, sustainable livestock production drives adoption of biotechnology-based feed additives globally 153   11.2.3.3 Animal health diagnostics 153 11.2.3.3.1 Growing disease incidence and need for early detection drive innovation in biotechnology-based animal diagnostics 153 11.2.3.4 Microbial biotechnology market, by type 153 11.2.3.4.1 Expanding use of microbes in agriculture enhances yield and sustainability 153 11.2.4 MICROBIAL BIOFERTILIZERS 155 11.2.4.1 Biocontrol agents (Fungi, Bacteria) 156 11.2.4.1.1 Stringent pesticide regulations and growing demand for residue-free, sustainable crop protection accelerate biocontrol adoption globally 156 11.2.4.2 Microbial enzymes & biostimulants 157 11.2.4.2.1 Rising demand for eco-friendly, stress-resilient crop enhancement solutions drives microbial enzyme and biostimulant adoption globally 157 11.2.4.3 Microbial genomics & fermentation 158 11.2.4.3.1 Advancements in microbial genomics and precision fermentation enable high-efficiency, scalable bio-based agricultural innovations globally 158 12 AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION 159 12.1 INTRODUCTION 160 12.2 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION 160 12.2.1 CROP PROTECTION 161 12.2.1.1 Increasing pest resistance and need for sustainable pest control drive innovation in biotech crop protection 161 12.2.2 YIELD ENHANCEMENT 162 12.2.2.1 Rising food demand and limited arable land accelerate adoption of high-yield biotechnology-based crop systems 162 12.2.3 NUTRITIONAL QUALITY IMPROVEMENT 162 12.2.3.1 Rising focus on combating micronutrient deficiency fuels demand for biotechnology-based nutritional crop improvement 162 12.2.4 CLIMATE-RESILIENT CROPS 162 12.2.4.1 Intensifying climate variability and food security concerns drive investment in biotechnology-based resilient crop development 162 12.3 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION 163 12.3.1 DISEASE RESISTANCE 164 12.3.1.1 Rising livestock disease outbreaks and antibiotic resistance drive adoption of genetic and molecular resistance solutions 164 12.3.2 GROWTH & PRODUCTIVITY ENHANCEMENT 164 12.3.2.1 Increasing protein demand and emission-reduction mandates promote biotechnology adoption for livestock growth and productivity enhancement 164 12.3.3 ANIMAL WELFARE SOLUTIONS 165 12.3.3.1 Rising ethical concerns and regulatory focus on humane production drive demand for biotechnology-enabled animal welfare systems 165   12.3.4 VETERINARY THERAPEUTICS 165 12.3.4.1 Growing prevalence of zoonotic diseases and advancements in biologics fuel growth of veterinary biotechnology therapeutics 165 12.4 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION 165 12.4.1 SOIL HEALTH MANAGEMENT 167 12.4.1.1 Increasing focus on regenerative agriculture and soil restoration drives adoption of microbial soil health management technologies 167 12.4.2 PEST & DISEASE CONTROL 167 12.4.2.1 Rising pesticide restrictions and demand for organic produce drive adoption of microbial pest control solutions 167 12.4.3 SUSTAINABLE NUTRIENT CYCLING 167 12.4.3.1 Growing nutrient inefficiency and fertilizer price volatility accelerate adoption of microbial nutrient cycling technologies 167 12.4.4 BIOREMEDIATION & WASTE UTILIZATION 168 12.4.4.1 Rising agricultural waste generation and environmental pollution drive adoption of microbial bioremediation technologies 168 13 AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY 169 13.1 INTRODUCTION 170 13.2 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY 170 13.2.1 TISSUE CULTURE 171 13.2.1.1 Growing need for disease-free, high-quality planting materials and export-grade crops accelerates tissue culture adoption globally 171 13.2.2 SOMATIC HYBRIDIZATION 172 13.2.2.1 Advancements in cell fusion and interspecies hybridization foster innovation in developing resilient and high-yield crop hybrids 172 13.2.3 MOLECULAR DIAGNOSTICS 172 13.2.3.1 Increasing global biosecurity regulations and focus on disease-free seed trade enhance molecular diagnostic adoption in agriculture 172 13.2.4 GENETIC ENGINEERING 172 13.2.4.1 Genetic engineering represents most transformative technology in modern plant biotechnology 172 13.3 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY 173 13.3.1 EMBRYO RESCUE & TRANSFER 174 13.3.1.1 Growing demand for genetic improvement, reproductive efficiency, and conservation drives widespread adoption of embryo transfer technologies 174 13.3.2 GENETIC ENGINEERING & CRISPR 175 13.3.2.1 Expanding use of CRISPR-Cas9 in livestock breeding drives precision genetic improvement and sustainability in animal farming 175 13.3.3 MOLECULAR DIAGNOSTICS 175 13.3.3.1 Rising livestock disease incidence and demand for rapid, accurate pathogen detection bolster molecular diagnostic adoption globally 175 13.3.4 VACCINE BIOTECHNOLOGIES 175 13.3.4.1 Rising zoonotic disease threats and focus on antibiotic-free livestock production accelerate biotech vaccine innovations globally 175 13.4 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY 176 13.4.1 FERMENTATION TECHNOLOGY 177 13.4.1.1 Increasing use of sustainable biofertilizers and precision fermentation drives growth in microbial input production technologies 177 13.4.2 METAGENOMICS & MICROBIAL GENOMICS 178 13.4.2.1 Expanding soil microbiome research and AI-based genomic analysis accelerate innovation in precision microbial biotechnology 178 13.4.3 MOLECULAR MARKER-ASSISTED SELECTION 178 13.4.3.1 Rising need for efficient microbial strain identification promotes adoption of molecular marker-assisted selection technologies 178 13.4.4 SYNTHETIC BIOLOGY 178 13.4.4.1 Expanding investments in engineered microbes and metabolic design accelerate adoption of synthetic biology in agriculture and biotechnology 178 14 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION 180 14.1 INTRODUCTION 181 14.2 NORTH AMERICA 184 14.2.1 US 195 14.2.1.1 Expanding bioengineering investments, AI-integrated field trials, and streamlined GMO regulations drive US biotechnology market leadership 195 14.2.2 CANADA 200 14.2.2.1 Supportive biosafety regulations and strong genomic research collaborations boost biotechnology advancement and sustainability in Canada 200 14.2.3 MEXICO 204 14.2.3.1 Expanding gene-editing research and sustainable agriculture policies accelerate biotechnology adoption and innovation in Mexico 204 14.3 EUROPE 208 14.3.1 GERMANY 219 14.3.1.1 Strong federal R&D support and industrial-scale bio-innovation reinforce Germany’s leadership in sustainable agricultural biotechnology 219 14.3.2 ITALY 223 14.3.2.1 Expanding bioinput research programs and regional sustainability initiatives accelerate biotechnology adoption in Italy’s agri-sector 223 14.3.3 FRANCE 227 14.3.3.1 Strong government R&D investment and progressive biosafety policies enhance France’s leadership in sustainable agricultural biotechnology 227 14.3.4 SPAIN 232 14.3.4.1 Expanding gene-editing research and strong government funding boost Spain’s sustainable agricultural biotechnology development 232 14.3.5 UK 236 14.3.5.1 Regulatory reforms and strong R&D investments strengthen UK’s leadership in precision agricultural biotechnology innovation 236 14.3.6 REST OF EUROPE 240 14.4 ASIA PACIFIC 245 14.4.1 CHINA 255 14.4.1.1 Expanding GMO approvals and strong state-led R&D investments reinforce China’s leadership in agricultural biotechnology innovation 255 14.4.2 INDIA 260 14.4.2.1 Government-led biotech missions and microbial innovation drive India’s agricultural transformation toward sustainable productivity growth 260 14.4.3 JAPAN 264 14.4.3.1 Strong government funding and innovation-driven industry partnerships accelerate Japan’s agricultural biotechnology advancement 264 14.4.4 AUSTRALIA & NEW ZEALAND 268 14.4.4.1 Progressive gene-editing reforms and climate-resilient R&D accelerate biotechnology growth in Australia and New Zealand 268 14.4.5 REST OF ASIA PACIFIC 273 14.5 SOUTH AMERICA 277 14.5.1 BRAZIL 287 14.5.1.1 Expanding GMO approvals and microbial innovation solidify Brazil’s leadership in agricultural biotechnology development 287 14.5.2 ARGENTINA 292 14.5.2.1 Global leadership in GM wheat and microbial bioinputs strengthens Argentina’s agricultural biotechnology innovation capacity 292 14.5.3 REST OF SOUTH AMERICA 296 14.6 REST OF THE WORLD 300 14.6.1 MIDDLE EAST 310 14.6.1.1 Government-backed innovation and food security strategies drive biotechnology adoption across Middle East’s arid regions 310 14.6.2 AFRICA 315 14.6.2.1 Expanding GM approvals and microbial innovation strengthen Africa’s resilience in sustainable agricultural biotechnology adoption 315 15 COMPETITIVE LANDSCAPE 320 15.1 OVERVIEW 320 15.2 KEY PLAYERS’ STRATEGIES, 2022–2024 320 15.3 REVENUE ANALYSIS, 2022–2024 328 15.4 MARKET SHARE ANALYSIS, 2024 331 15.5 BRAND/PRODUCT COMPARISON 335 15.5.1 BAYER AG (GERMANY) 335 15.5.2 SYNGENTA AG (SWITZERLAND) 336 15.5.3 CORTEVA (US) 336 15.5.4 ZOETIS INC. (US) 336 15.5.5 NOVONESIS GROUP (DENMARK) 336   15.6 COMPANY VALUATION AND FINANCIAL METRICS 337 15.6.1 COMPANY VALUATION 337 15.6.2 EV/EBITDA 337 15.7 PLANT BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 338 15.7.1 STARS 338 15.7.2 EMERGING LEADERS 338 15.7.3 PERVASIVE PLAYERS 338 15.7.4 PARTICIPANTS 339 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 340 15.7.5.1 Company footprint 340 15.7.5.2 Region footprint 340 15.7.5.3 Type footprint 341 15.7.5.4 Application footprint 341 15.8 ANIMAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 342 15.8.1 STARS 342 15.8.2 EMERGING LEADERS 342 15.8.3 PERVASIVE PLAYERS 342 15.8.4 PARTICIPANTS 343 15.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 344 15.8.5.1 Company footprint 344 15.8.5.2 Region footprint 344 15.8.5.3 Type footprint 345 15.8.5.4 Application footprint 345 15.9 MICROBIAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 346 15.9.1 STARS 346 15.9.2 EMERGING LEADERS 346 15.9.3 PERVASIVE PLAYERS 346 15.9.4 PARTICIPANTS 347 15.9.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 348 15.9.5.1 Company footprint 348 15.9.5.2 Region footprint 348 15.9.5.3 Type footprint 349 15.9.5.4 Application footprint 349 15.10 COMPETITIVE SCENARIO 350 15.10.1 PRODUCT LAUNCHES 350 15.10.2 DEALS 352 15.10.3 EXPANSIONS 353   16 COMPANY PROFILES 356 16.1 PLANT BIOTECHNOLOGY COMPANIES 356 16.1.1 BASF SE 356 16.1.1.1 Business overview 356 16.1.1.2 Products/Solutions/Services offered 358 16.1.1.3 Recent developments 359 16.1.1.3.1 Product launches 359 16.1.1.3.2 Deals 360 16.1.1.3.3 Expansions 360 16.1.1.4 MnM view 361 16.1.1.4.1 Key strengths 361 16.1.1.4.2 Strategic choices 361 16.1.1.4.3 Weaknesses and competitive threats 361 16.1.2 BAYER AG 362 16.1.2.1 Business overview 362 16.1.2.2 Products/Solutions/Services offered 363 16.1.2.3 Recent developments 364 16.1.2.3.1 Product launches 364 16.1.2.3.2 Deals 365 16.1.2.3.3 Expansions 367 16.1.2.4 MnM view 367 16.1.2.4.1 Key strengths 367 16.1.2.4.2 Strategic choices 367 16.1.2.4.3 Weaknesses and competitive threats 368 16.1.3 CORTEVA AGRISCIENCE 369 16.1.3.1 Business overview 369 16.1.3.2 Products/Solutions/Services offered 370 16.1.3.3 Recent developments 372 16.1.3.3.1 Product launches 372 16.1.3.3.2 Deals 373 16.1.3.4 MnM view 375 16.1.3.4.1 Key strengths 375 16.1.3.4.2 Strategic choices 375 16.1.3.4.3 Weaknesses and competitive threats 376 16.1.4 SYNGENTA 377 16.1.4.1 Business overview 377 16.1.4.2 Products/Solutions/Services offered 378 16.1.4.3 Recent developments 381 16.1.4.3.1 Product launches 381 16.1.4.3.2 Deals 382 16.1.4.3.3 Expansions 386   16.1.4.4 MnM view 387 16.1.4.4.1 Key strengths 387 16.1.4.4.2 Strategic choices 387 16.1.4.4.3 Weaknesses and competitive threats 387 16.1.5 KWS SAAT SE & CO. KGAA 388 16.1.5.1 Business overview 388 16.1.5.2 Products/Solutions/Services offered 389 16.1.5.3 Recent developments 391 16.1.5.3.1 Product launches 391 16.1.5.3.2 Deals 391 16.1.5.3.3 Other developments 392 16.1.5.4 MnM view 392 16.1.5.4.1 Key strengths 392 16.1.5.4.2 Strategic choices 392 16.1.5.4.3 Weaknesses and competitive threats 393 16.1.6 UPL 394 16.1.6.1 Business overview 394 16.1.6.2 Products/Solutions/Services offered 395 16.1.6.3 Recent developments 397 16.1.6.3.1 Product launches 397 16.1.6.3.2 Deals 399 16.1.6.4 MnM view 400 16.1.6.4.1 Key strengths 400 16.1.6.4.2 Strategic choices 401 16.1.6.4.3 Weaknesses and competitive threats 401 16.1.7 FMC CORPORATION 402 16.1.7.1 Business overview 402 16.1.7.2 Products/Solutions/Services offered 403 16.1.7.3 Recent developments 404 16.1.7.3.1 Product launches 404 16.1.7.3.2 Deals 405 16.1.7.3.3 Expansions 407 16.1.7.3.4 Other developments 407 16.1.7.4 MnM view 408 16.1.8 SUMITOMO CHEMICAL CO., LTD. 409 16.1.8.1 Business overview 409 16.1.8.2 Products/Solutions/Services offered 410 16.1.8.3 Recent developments 410 16.1.8.3.1 Deals 410 16.1.8.3.2 Expansions 411 16.1.8.4 MnM view 412   16.1.9 NUFARM 413 16.1.9.1 Business overview 413 16.1.9.2 Products/Solutions/Services offered 414 16.1.9.3 Recent developments 415 16.1.9.3.1 Product launches 415 16.1.9.3.2 Deals 415 16.1.9.4 MnM view 416 16.1.10 PRO FARM GROUP 417 16.1.10.1 Business overview 417 16.1.10.2 Products/Solutions/Services offered 418 16.1.10.3 Recent developments 419 16.1.10.3.1 Product launches 419 16.1.10.4 MnM view 419 16.2 ANIMAL BIOTECHNOLOGY COMPANIES 420 16.2.1 ZOETIS SERVICES LLC 420 16.2.1.1 Business overview 420 16.2.1.2 Products/Solutions/Services offered 421 16.2.1.3 Recent developments 422 16.2.1.3.1 Other developments 422 16.2.1.3.2 Expansions 422 16.2.1.4 MnM view 423 16.2.1.4.1 Key strengths 423 16.2.1.4.2 Strategic choices 423 16.2.1.4.3 Weaknesses and competitive threats 423 16.2.2 ELANCO OR ITS AFFILIATES 424 16.2.2.1 Business overview 424 16.2.2.2 Products/Solutions/Services offered 425 16.2.2.3 Recent developments 426 16.2.2.3.1 Product launches 426 16.2.2.4 MnM view 426 16.2.2.4.1 Key strengths 426 16.2.2.4.2 Strategic choices 427 16.2.2.4.3 Weaknesses and competitive threats 427 16.2.3 MERCK & CO., INC. 428 16.2.3.1 Business overview 428 16.2.3.2 Products/Solutions/Services offered 429 16.2.3.3 Recent developments 430 16.2.3.3.1 Expansions 430 16.2.3.4 MnM view 430 16.2.3.4.1 Key strengths 430 16.2.3.4.2 Strategic choices 430 16.2.3.4.3 Weaknesses and competitive threats 431 16.2.4 CEVA 432 16.2.4.1 Business overview 432 16.2.4.2 Products/Solutions/Services offered 432 16.2.4.3 Recent developments 433 16.2.4.3.1 Expansions 433 16.2.4.4 MnM view 434 16.2.5 VIRBAC 435 16.2.5.1 Business overview 435 16.2.5.2 Products/Solutions/Services offered 436 16.2.5.3 Recent developments 437 16.2.5.3.1 Product launches 437 16.2.5.4 MnM view 437 16.2.5.4.1 Key strengths 437 16.2.5.4.2 Strategic choices 437 16.2.5.4.3 Weaknesses and competitive threats 438 16.2.6 HESTER BIOSCIENCES LIMITED 439 16.2.6.1 Business overview 439 16.2.6.2 Products/Solutions/Services offered 440 16.2.6.3 MnM view 441 16.2.7 GENUS PLC 442 16.2.7.1 Business overview 442 16.2.7.2 Products/Solutions/Services offered 443 16.2.7.3 MnM view 444 16.2.8 VAXXINOVA 445 16.2.8.1 Business overview 445 16.2.8.2 Products/Solutions/Services offered 445 16.2.8.3 MnM view 446 16.2.9 AB VISTA 447 16.2.9.1 Business overview 447 16.2.9.2 Products/Solutions/Services offered 447 16.2.9.3 MnM view 448 16.2.10 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 449 16.2.10.1 Business overview 449 16.2.10.2 Products/Solutions/Services offered 450 16.2.10.3 Recent developments 451 16.2.10.3.1 Product launches 451 16.2.10.4 MnM view 452 16.2.10.4.1 Key strengths 452 16.2.10.4.2 Strategic choices 452 16.2.10.4.3 Weaknesses and competitive threats 452   16.3 MICROBE BIOTECHNOLOGY COMPANIES 453 16.3.1 VALENT U.S.A. LLC 453 16.3.1.1 Business overview 453 16.3.1.2 Products/Solutions/Services offered 454 16.3.1.3 Recent developments 455 16.3.1.3.1 Deals 455 16.3.1.3.2 Expansions 455 16.3.1.4 MnM view 455 16.3.1.4.1 Key strengths 455 16.3.1.4.2 Strategic choices 456 16.3.1.4.3 Weaknesses and competitive threats 456 16.3.2 NOVONESIS GROUP 457 16.3.2.1 Business overview 457 16.3.2.2 Products/Solutions/Services offered 458 16.3.2.3 Recent developments 459 16.3.2.3.1 Product launches 459 16.3.2.3.2 Deals 459 16.3.2.3.3 Expansions 460 16.3.2.4 MnM view 460 16.3.2.4.1 Key strengths 460 16.3.2.4.2 Strategic choices 460 16.3.2.4.3 Weaknesses and competitive threats 461 16.3.3 INDIGO AG, INC. 462 16.3.3.1 Business overview 462 16.3.3.2 Products/Solutions/Services offered 463 16.3.3.3 Recent developments 464 16.3.3.3.1 Product launches 464 16.3.3.3.2 Deals 464 16.3.3.3.3 Expansions 465 16.3.3.4 MnM view 465 16.3.3.4.1 Key strengths 465 16.3.3.4.2 Strategic choices 465 16.3.3.4.3 Weaknesses and competitive threats 465 16.3.4 PIVOT BIO 466 16.3.4.1 Business overview 466 16.3.4.2 Products/Solutions/Services offered 467 16.3.4.3 Recent developments 467 16.3.4.3.1 Other developments 467 16.3.4.3.2 Expansions 468 16.3.4.4 MnM view 468 16.3.4.4.1 Key strengths 468 16.3.4.4.2 Strategic choices 469 16.3.4.4.3 Weaknesses and competitive threats 469 16.3.5 BIOATLANTIS LTD. 470 16.3.5.1 Business overview 470 16.3.5.2 Products/Solutions/Services offered 471 16.3.5.3 Recent developments 471 16.3.5.3.1 Product launches 471 16.3.5.3.2 Deals 472 16.3.5.4 MnM view 472 16.3.5.4.1 Key strengths 472 16.3.5.4.2 Strategic choices 473 16.3.5.4.3 Weaknesses and competitive threats 473 16.3.6 CERTIS USA L.L.C. 474 16.3.6.1 Business overview 474 16.3.6.2 Products/Solutions/Services offered 475 16.3.6.3 Recent developments 477 16.3.6.3.1 Product launches 477 16.3.6.3.2 Deals 477 16.3.6.4 MnM view 477 16.3.7 ZYMOLENT BIOSCIENCES PVT. LTD. 478 16.3.7.1 Business overview 478 16.3.7.2 Products/Solutions/Services offered 479 16.3.7.3 Recent developments 479 16.3.7.3.1 Other developments 479 16.3.7.4 MnM view 479 16.3.8 AGRICEN 480 16.3.8.1 Business overview 480 16.3.8.2 Products/Solutions/Services offered 481 16.3.8.3 Recent developments 481 16.3.8.3.1 Deals 481 16.3.8.4 MnM view 482 16.3.9 VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD. 483 16.3.9.1 Business overview 483 16.3.9.2 Products/Solutions/Services offered 484 16.3.9.3 Recent developments 486 16.3.9.4 MnM view 486 16.3.10 GROUNDWORK BIOAG 487 16.3.10.1 Business overview 487 16.3.10.2 Products/Solutions/Services offered 488 16.3.10.3 Recent developments 489 16.3.10.3.1 Product launches 489 16.3.10.3.2 Deals 489 16.3.10.4 MnM view 490 17 ADJACENT AND RELATED MARKETS 491 17.1 INTRODUCTION 491 17.2 LIMITATIONS 491 17.3 PLANT BIOTECHNOLOGY MARKET 491 17.3.1 MARKET DEFINITION 491 17.3.2 MARKET OVERVIEW 492 17.4 AGRICULTURAL MICROBIALS MARKET 493 17.4.1 MARKET DEFINITION 493 17.4.2 AGRICULTURAL MICROBIALS MARKET, BY APPLICATION 493 18 APPENDIX 495 18.1 DISCUSSION GUIDE 495 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 503 18.3 CUSTOMIZATION OPTIONS 505 18.4 RELATED REPORTS 506 18.5 AUTHOR DETAILS 506
圖表清單 List of Tables & Figures
TABLE 1 USD EXCHANGE RATES, 2020–2024 50 TABLE 2 AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT, 2025 VS. 2030 65 TABLE 3 AGRICULTURE BIOTECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 87 TABLE 4 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR PLANT BIOTECHNOLOGY 95 TABLE 5 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR MICROBIAL BIOTECHNOLOGY 96 TABLE 6 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR ANIMAL BIOTECHNOLOGY 96 TABLE 7 PLANT BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024 97 TABLE 8 MICROBIAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024 98 TABLE 9 ANIMAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024 98 TABLE 10 TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND) 101 TABLE 11 TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND) 102 TABLE 12 TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (TONS) 102 TABLE 13 TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (TONS) 103 TABLE 14 AGRICULTURE BIOTECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 103 TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 108 TABLE 16 EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT 109 TABLE 17 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES 110 TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE 113 TABLE 19 KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE 114 TABLE 20 LIST OF MAJOR PATENTS FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2021–2024 120 TABLE 21 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 130 TABLE 22 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 131 TABLE 23 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 131 TABLE 24 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 132 TABLE 25 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 132 TABLE 26 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2020–2024 (USD MILLION) 138 TABLE 27 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2025–2030 (USD MILLION) 139 TABLE 28 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 139 TABLE 29 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 140 TABLE 30 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 141 TABLE 31 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 141 TABLE 32 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 142 TABLE 33 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 142 TABLE 34 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 145 TABLE 35 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 145 TABLE 36 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 146 TABLE 37 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 146 TABLE 38 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 146 TABLE 39 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 147 TABLE 40 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 147 TABLE 41 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 147 TABLE 42 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 148 TABLE 43 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 148 TABLE 44 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 148 TABLE 45 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 149 TABLE 46 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 151 TABLE 47 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 152 TABLE 48 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 154 TABLE 49 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 154 TABLE 50 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS) 155 TABLE 51 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS) 155 TABLE 52 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 156 TABLE 53 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 156 TABLE 54 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 157 TABLE 55 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 157 TABLE 56 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 161 TABLE 57 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 161 TABLE 58 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 163 TABLE 59 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 164 TABLE 60 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 166 TABLE 61 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 166 TABLE 62 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 171 TABLE 63 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 171 TABLE 64 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 174 TABLE 65 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 174 TABLE 66 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 177 TABLE 67 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 177 TABLE 68 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 182 TABLE 69 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 182 TABLE 70 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 182 TABLE 71 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 183 TABLE 72 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 183 TABLE 73 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 183 TABLE 74 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 184 TABLE 75 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 184 TABLE 76 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 185 TABLE 77 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 186 TABLE 78 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 186 TABLE 79 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 186 TABLE 80 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 187 TABLE 81 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 187 TABLE 82 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 187 TABLE 83 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 188 TABLE 84 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 188 TABLE 85 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 188 TABLE 86 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 189 TABLE 87 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 189 TABLE 88 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 189 TABLE 89 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 190 TABLE 90 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 190 TABLE 91 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 190 TABLE 92 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 191 TABLE 93 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 191 TABLE 94 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 191 TABLE 95 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 192 TABLE 96 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 192 TABLE 97 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 192 TABLE 98 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 193 TABLE 99 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 193 TABLE 100 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS) 193 TABLE 101 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS) 194 TABLE 102 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 194 TABLE 103 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 194 TABLE 104 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 195 TABLE 105 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 195 TABLE 106 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 196 TABLE 107 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 196 TABLE 108 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 196 TABLE 109 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 197 TABLE 110 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 197 TABLE 111 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 197 TABLE 112 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 198 TABLE 113 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 198 TABLE 114 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 198 TABLE 115 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 199 TABLE 116 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 199 TABLE 117 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 199 TABLE 118 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 200 TABLE 119 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 200 TABLE 120 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 201 TABLE 121 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 201 TABLE 122 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 201 TABLE 123 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 202 TABLE 124 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 202 TABLE 125 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 202 TABLE 126 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 203 TABLE 127 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 203 TABLE 128 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 203 TABLE 129 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 204 TABLE 130 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 204 TABLE 131 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 205 TABLE 132 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 205 TABLE 133 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 205 TABLE 134 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 206 TABLE 135 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 206 TABLE 136 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 206 TABLE 137 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 207 TABLE 138 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 207 TABLE 139 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 207 TABLE 140 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 208 TABLE 141 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 208 TABLE 142 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 209 TABLE 143 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 209 TABLE 144 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 209 TABLE 145 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 210 TABLE 146 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 210 TABLE 147 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 210 TABLE 148 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 211 TABLE 149 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 211 TABLE 150 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 211 TABLE 151 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 212 TABLE 152 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 212 TABLE 153 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 212 TABLE 154 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 213 TABLE 155 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 213 TABLE 156 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 213 TABLE 157 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 214 TABLE 158 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 214 TABLE 159 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 214 TABLE 160 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 215 TABLE 161 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 215 TABLE 162 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 215 TABLE 163 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 216 TABLE 164 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 216 TABLE 165 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 216 TABLE 166 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS) 217 TABLE 167 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS) 217 TABLE 168 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 217 TABLE 169 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 218 TABLE 170 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 218 TABLE 171 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 218 TABLE 172 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 219 TABLE 173 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 219 TABLE 174 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 220 TABLE 175 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 220 TABLE 176 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 220 TABLE 177 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 221 TABLE 178 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 221 TABLE 179 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 221 TABLE 180 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 222 TABLE 181 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 222 TABLE 182 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 222 TABLE 183 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 223 TABLE 184 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 223 TABLE 185 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 224 TABLE 186 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 224 TABLE 187 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 224 TABLE 188 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 225 TABLE 189 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 225 TABLE 190 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 225 TABLE 191 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 226 TABLE 192 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 226 TABLE 193 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 226 TABLE 194 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 227 TABLE 195 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 227 TABLE 196 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 228 TABLE 197 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 228 TABLE 198 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 228 TABLE 199 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 229 TABLE 200 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 229 TABLE 201 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 229 TABLE 202 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 230 TABLE 203 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 230 TABLE 204 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 230 TABLE 205 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 231 TABLE 206 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 231 TABLE 207 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 231 TABLE 208 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 232 TABLE 209 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 232 TABLE 210 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 233 TABLE 211 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 233 TABLE 212 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 233 TABLE 213 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 234 TABLE 214 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 234 TABLE 215 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 234 TABLE 216 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 235 TABLE 217 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 235 TABLE 218 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 235 TABLE 219 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 236 TABLE 220 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 236 TABLE 221 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 237 TABLE 222 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 237 TABLE 223 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 237 TABLE 224 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 238 TABLE 225 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 238 TABLE 226 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 238 TABLE 227 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 239 TABLE 228 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 239 TABLE 229 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 239 TABLE 230 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 240 TABLE 231 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 240 TABLE 232 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 241 TABLE 233 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 241 TABLE 234 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 241 TABLE 235 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 242 TABLE 236 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 242 TABLE 237 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 242 TABLE 238 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 243 TABLE 239 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 243 TABLE 240 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 243 TABLE 241 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 244 TABLE 242 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 244 TABLE 243 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 244 TABLE 244 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 246 TABLE 245 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 246 TABLE 246 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 246 TABLE 247 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 247 TABLE 248 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 247 TABLE 249 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 247 TABLE 250 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 248 TABLE 251 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 248 TABLE 252 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 248 TABLE 253 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 249 TABLE 254 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 249 TABLE 255 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 249 TABLE 256 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 250 TABLE 257 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 250 TABLE 258 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 250 TABLE 259 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 251 TABLE 260 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 251 TABLE 261 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 251 TABLE 262 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 252 TABLE 263 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 252 TABLE 264 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 252 TABLE 265 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 253 TABLE 266 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 253 TABLE 267 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 253 TABLE 268 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS) 254 TABLE 269 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS) 254 TABLE 270 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 254 TABLE 271 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 254 TABLE 272 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 255 TABLE 273 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 255 TABLE 274 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 256 TABLE 275 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 256 TABLE 276 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 256 TABLE 277 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 257 TABLE 278 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 257 TABLE 279 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 257 TABLE 280 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 258 TABLE 281 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 258 TABLE 282 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 258 TABLE 283 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 259 TABLE 284 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 259 TABLE 285 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 259 TABLE 286 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 260 TABLE 287 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 260 TABLE 288 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 261 TABLE 289 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 261 TABLE 290 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 261 TABLE 291 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 262 TABLE 292 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 262 TABLE 293 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 262 TABLE 294 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 263 TABLE 295 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 263 TABLE 296 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 263 TABLE 297 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 264 TABLE 298 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 264 TABLE 299 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 265 TABLE 300 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 265 TABLE 301 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 265 TABLE 302 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 266 TABLE 303 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 266 TABLE 304 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 266 TABLE 305 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 267 TABLE 306 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 267 TABLE 307 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 267 TABLE 308 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 268 TABLE 309 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 268 TABLE 310 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 269 TABLE 311 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 269 TABLE 312 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 269 TABLE 313 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 270 TABLE 314 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 270 TABLE 315 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 270 TABLE 316 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 271 TABLE 317 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 271 TABLE 318 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 271 TABLE 319 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 272 TABLE 320 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 272 TABLE 321 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 272 TABLE 322 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 273 TABLE 323 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 273 TABLE 324 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 274 TABLE 325 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 274 TABLE 326 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 274 TABLE 327 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 275 TABLE 328 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 275 TABLE 329 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 275 TABLE 330 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 276 TABLE 331 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 276 TABLE 332 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 276 TABLE 333 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 277 TABLE 334 SOUTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 277 TABLE 335 SOUTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 278 TABLE 336 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 278 TABLE 337 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 278 TABLE 338 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 279 TABLE 339 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 279 TABLE 340 SOUTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 279 TABLE 341 SOUTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 280 TABLE 342 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 280 TABLE 343 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 280 TABLE 344 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 281 TABLE 345 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 281 TABLE 346 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 281 TABLE 347 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 282 TABLE 348 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 282 TABLE 349 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 282 TABLE 350 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 283 TABLE 351 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 283 TABLE 352 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 283 TABLE 353 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 284 TABLE 354 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 284 TABLE 355 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 284 TABLE 356 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 285 TABLE 357 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 285 TABLE 358 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS) 285 TABLE 359 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS) 286 TABLE 360 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 286 TABLE 361 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 286 TABLE 362 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 287 TABLE 363 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 287 TABLE 364 BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 288 TABLE 365 BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 288 TABLE 366 BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 288 TABLE 367 BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 289 TABLE 368 BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 289 TABLE 369 BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 289 TABLE 370 BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 290 TABLE 371 BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 290 TABLE 372 BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 290 TABLE 373 BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 291 TABLE 374 BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 291 TABLE 375 BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 291 TABLE 376 ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 292 TABLE 377 ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 292 TABLE 378 ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 293 TABLE 379 ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 293 TABLE 380 ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 293 TABLE 381 ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 294 TABLE 382 ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 294 TABLE 383 ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 294 TABLE 384 ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 295 TABLE 385 ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 295 TABLE 386 ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 295 TABLE 387 ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 296 TABLE 388 REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 296 TABLE 389 REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 297 TABLE 390 REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 297 TABLE 391 REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 297 TABLE 392 REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 298 TABLE 393 REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 298 TABLE 394 REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 298 TABLE 395 REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 299 TABLE 396 REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 299 TABLE 397 REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 299 TABLE 398 REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 300 TABLE 399 REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 300 TABLE 400 REST OF THE WORLD: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 301 TABLE 401 REST OF THE WORLD: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 301 TABLE 402 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 301 TABLE 403 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 301 TABLE 404 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 302 TABLE 405 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 302 TABLE 406 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 302 TABLE 407 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 303 TABLE 408 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 303 TABLE 409 REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 303 TABLE 410 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 304 TABLE 411 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 304 TABLE 412 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 304 TABLE 413 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 305 TABLE 414 REST OF THE WORLD CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 305 TABLE 415 REST OF THE WORLD CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 305 TABLE 416 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 306 TABLE 417 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 306 TABLE 418 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 306 TABLE 419 REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 307 TABLE 420 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 307 TABLE 421 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 307 TABLE 422 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 308 TABLE 423 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 308 TABLE 424 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS) 308 TABLE 425 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS) 309 TABLE 426 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION) 309 TABLE 427 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 309 TABLE 428 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 310 TABLE 429 REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 310 TABLE 430 MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 311 TABLE 431 MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 311 TABLE 432 MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 311 TABLE 433 MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 312 TABLE 434 MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 312 TABLE 435 MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 312 TABLE 436 MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 313 TABLE 437 MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 313 TABLE 438 MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 313 TABLE 439 MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 314 TABLE 440 MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 314 TABLE 441 MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 314 TABLE 442 AFRICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 315 TABLE 443 AFRICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 315 TABLE 444 AFRICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 316 TABLE 445 AFRICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 316 TABLE 446 AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 316 TABLE 447 AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 317 TABLE 448 AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 317 TABLE 449 AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 317 TABLE 450 AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 318 TABLE 451 AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 318 TABLE 452 AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 318 TABLE 453 AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 319 TABLE 454 COMPETITIVE STRATEGY INITIATIVES (PLANT BIOTECHNOLOGY MARKET) 321 TABLE 455 COMPETITIVE STRATEGY INITIATIVES (ANIMAL BIOTECHNOLOGY MARKET) 324 TABLE 456 COMPETITIVE STRATEGY INITIATIVES (MICROBIAL BIOTECHNOLOGY MARKET) 326 TABLE 457 PLANT BIOTECHNOLOGY MARKET: DEGREE OF COMPETITION 332 TABLE 458 ANIMAL BIOTECHNOLOGY MARKET: DEGREE OF COMPETITION 333 TABLE 459 MICROBIAL BIOTECHNOLOGY MARKET: DEGREE OF COMPETITION 334 TABLE 460 PLANT BIOTECHNOLOGY MARKET: REGION FOOTPRINT 340 TABLE 461 PLANT BIOTECHNOLOGY MARKET: TYPE FOOTPRINT 341 TABLE 462 PLANT BIOTECHNOLOGY MARKET: APPLICATION FOOTPRINT 341 TABLE 463 ANIMAL BIOTECHNOLOGY MARKET: REGION FOOTPRINT 344 TABLE 464 ANIMAL BIOTECHNOLOGY MARKET: TYPE FOOTPRINT 345 TABLE 465 ANIMAL BIOTECHNOLOGY MARKET: APPLICATION FOOTPRINT 345 TABLE 466 MICROBIAL BIOTECHNOLOGY MARKET: REGION FOOTPRINT 348 TABLE 467 MICROBIAL BIOTECHNOLOGY MARKET: TYPE FOOTPRINT 349 TABLE 468 MICROBIAL BIOTECHNOLOGY MARKET: APPLICATION FOOTPRINT 349 TABLE 469 AGRICULTURE BIOTECHNOLOGY MARKET: PRODUCT LAUNCHES, MARCH 2021–SEPTEMBER 2025 350 TABLE 470 AGRICULTURE BIOTECHNOLOGY MARKET: DEALS, JULY 2023–AUGUST 2025 352 TABLE 471 AGRICULTURE BIOTECHNOLOGY MARKET: EXPANSIONS, JULY 2021–MAY 2025 354 TABLE 472 BASF SE: COMPANY OVERVIEW 357 TABLE 473 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 358 TABLE 474 BASF SE: PRODUCT LAUNCHES 359 TABLE 475 BASF SE: DEALS 360 TABLE 476 BASF SE: EXPANSIONS 360 TABLE 477 BAYER AG: COMPANY OVERVIEW 362 TABLE 478 BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 363 TABLE 479 BAYER AG: PRODUCT LAUNCHES 364 TABLE 480 BAYER AG: DEALS 365 TABLE 481 BAYER AG: EXPANSIONS 367 TABLE 482 CORTEVA AGRISCIENCE: COMPANY OVERVIEW 369 TABLE 483 CORTEVA AGRISCIENCE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 370 TABLE 484 CORTEVA AGRISCIENCE: PRODUCT LAUNCHES 372 TABLE 485 CORTEVA AGRISCIENCE: DEALS 373 TABLE 486 SYNGENTA: COMPANY OVERVIEW 377 TABLE 487 SYNGENTA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 378 TABLE 488 SYNGENTA: PRODUCT LAUNCHES 381 TABLE 489 SYNGENTA: DEALS 382 TABLE 490 SYNGENTA: EXPANSIONS 386 TABLE 491 KWS SAAT SE & CO. KGAA: COMPANY OVERVIEW 388 TABLE 492 KWS SAAT SE & CO. KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 389 TABLE 493 KWS SAAT SE & CO. KGAA: PRODUCT LAUNCHES 391 TABLE 494 KWS SAAT SE & CO. KGAA: DEALS 391 TABLE 495 KWS SAAT SE & CO. KGAA: OTHER DEVELOPMENTS 392 TABLE 496 UPL: COMPANY OVERVIEW 394 TABLE 497 UPL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 395 TABLE 498 UPL: PRODUCT LAUNCHES 397 TABLE 499 UPL: DEALS 399 TABLE 500 FMC CORPORATION: COMPANY OVERVIEW 402 TABLE 501 FMC CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 403 TABLE 502 FMC CORPORATION: PRODUCT LAUNCHES 404 TABLE 503 FMC CORPORATION: DEALS 405 TABLE 504 FMC CORPORATION: EXPANSIONS 407 TABLE 505 FMC CORPORATION: OTHER DEVELOPMENTS 407 TABLE 506 SUMITOMO CHEMICAL CO., LTD.: COMPANY OVERVIEW 409 TABLE 507 SUMITOMO CHEMICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 410 TABLE 508 SUMITOMO CHEMICAL CO., LTD.: DEALS 410 TABLE 509 SUMITOMO CHEMICAL CO., LTD.: EXPANSIONS 411 TABLE 510 NUFARM: COMPANY OVERVIEW 413 TABLE 511 NUFARM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 414 TABLE 512 NUFARM: PRODUCT LAUNCHES 415 TABLE 513 NUFARM: DEALS 415 TABLE 514 PRO FARM GROUP: COMPANY OVERVIEW 417 TABLE 515 PRO FARM GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 418 TABLE 516 PRO FARM GROUP: PRODUCT LAUNCHES 419 TABLE 517 ZOETIS INC.: COMPANY OVERVIEW 420 TABLE 518 ZOETIS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 421 TABLE 519 ZOETIS INC.: OTHER DEVELOPMENTS 422 TABLE 520 ZOETIS INC: EXPANSIONS 422 TABLE 521 ELANCO OR ITS AFFILIATES: COMPANY OVERVIEW 424 TABLE 522 ELANCO OR ITS AFFILIATES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 425 TABLE 523 ELANCO OR ITS AFFILIATES: PRODUCT LAUNCHES 426 TABLE 524 MERCK & CO., INC.: COMPANY OVERVIEW 428 TABLE 525 MERCK & CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 429 TABLE 526 MERCK & CO., INC.: EXPANSIONS 430 TABLE 527 CEVA: COMPANY OVERVIEW 432 TABLE 528 CEVA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 432 TABLE 529 CEVA: EXPANSIONS 433 TABLE 530 VIRBAC: COMPANY OVERVIEW 435 TABLE 531 VIRBAC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 436 TABLE 532 VIRBAC: PRODUCT LAUNCHES 437 TABLE 533 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW 439 TABLE 534 HESTER BIOSCIENCES LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 440 TABLE 535 GENUS PLC: COMPANY OVERVIEW 442 TABLE 536 GENUS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 443 TABLE 537 VAXXINOVA: COMPANY OVERVIEW 445 TABLE 538 VAXXINOVA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 445 TABLE 539 AB VISTA: COMPANY OVERVIEW 447 TABLE 540 AB VISTA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 447 TABLE 541 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW 449 TABLE 542 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 450 TABLE 543 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT LAUNCHES 451 TABLE 544 VALENT U.S.A. LLC: COMPANY OVERVIEW 453 TABLE 545 VALENT U.S.A. LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 454 TABLE 546 VALENT U.S.A. LLC: DEALS 455 TABLE 547 VALENT U.S.A. LLC: EXPANSIONS 455 TABLE 548 NOVONESIS GROUP: COMPANY OVERVIEW 457 TABLE 549 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 458 TABLE 550 NOVONESIS GROUP: PRODUCT LAUNCHES 459 TABLE 551 NOVONESIS GROUP: DEALS 459 TABLE 552 NOVONESIS GROUP: EXPANSIONS 460 TABLE 553 INDIGO AG, INC.: COMPANY OVERVIEW 462 TABLE 554 INDIGO AG, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 463 TABLE 555 INDIGO AG, INC.: PRODUCT LAUNCHES 464 TABLE 556 INDIGO AG, INC.: DEALS 464 TABLE 557 INDIGO AG, INC.: EXPANSIONS 465 TABLE 558 PIVOT BIO: COMPANY OVERVIEW 466 TABLE 559 PIVOT BIO.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 467 TABLE 560 PIVOT BIO: OTHER DEVELOPMENTS 467 TABLE 561 PIVOT BIO.: EXPANSIONS 468 TABLE 562 BIOATLANTIS LTD.: COMPANY OVERVIEW 470 TABLE 563 BIOATLANTIS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 471 TABLE 564 BIOATLANTIS LTD.: PRODUCT LAUNCHES 471 TABLE 565 BIOATLANTIS LTD.: DEALS 472 TABLE 566 CERTIS USA L.L.C.: COMPANY OVERVIEW 474 TABLE 567 CERTIS USA L.L.C.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 475 TABLE 568 CERTIS USA L.L.C.: PRODUCT LAUNCHES 477 TABLE 569 CERTIS USA L.L.C.: DEALS 477 TABLE 570 ZYMOLENT BIOSCIENCES PVT. LTD.: COMPANY OVERVIEW 478 TABLE 571 ZYMOLENT BIOSCIENCES PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 479 TABLE 572 ZYMOLENT BIOSCIENCES PVT. LTD.: OTHER DEVELOPMENTS 479 TABLE 573 AGRICEN: COMPANY OVERVIEW 480 TABLE 574 AGRICEN: PRODUCTS/SOLUTIONS/SERVICES OFFERED 481 TABLE 575 AGRICEN: DEALS 481 TABLE 576 VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD.: COMPANY OVERVIEW 483 TABLE 577 VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 484 TABLE 578 GROUNDWORK BIOAG: COMPANY OVERVIEW 487 TABLE 579 GROUNDWORK BIOAG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 488 TABLE 580 GROUNDWORK BIOAG: PRODUCT LAUNCHES 489 TABLE 581 GROUNDWORK BIOAG: DEALS 489 TABLE 582 ADJACENT MARKETS TO AGRICULTURE BIOTECHNOLOGY MARKET 491 TABLE 583 PLANT BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 492 TABLE 584 PLANT BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 493 TABLE 585 AGRICULTURAL MICROBIALS MARKET, BY APPLICATION, 2019–2024 (USD MILLION) 494 TABLE 586 AGRICULTURAL MICROBIALS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 494 FIGURE 1 MARKET SEGMENTATION AND REGIONS COVERED 47 FIGURE 2 AGRICULTURE BIOTECHNOLOGY MARKET: RESEARCH DESIGN 52 FIGURE 3 BRIEF OF BOTTOM-UP APPROACH 57 FIGURE 4 AGRICULTURAL BIOTECHNOLOGY MARKET: BOTTOM-UP APPROACH 58 FIGURE 5 AGRICULTURAL BIOTECHNOLOGY MARKET: TOP-DOWN APPROACH 59 FIGURE 6 BRIEF OF TOP-DOWN APPROACH 60 FIGURE 7 DATA TRIANGULATION 61 FIGURE 8 AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 67 FIGURE 9 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 67 FIGURE 10 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 68 FIGURE 11 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 69 FIGURE 12 AGRICULTURE BIOTECHNOLOGY MARKET SHARE, BY REGION 70 FIGURE 13 ADVANCEMENTS IN GENE EDITING, DIGITAL AGRICULTURE, AND MICROBIAL TECHNOLOGIES TO ACCELERATE GLOBAL AGRICULTURE BIOTECHNOLOGY ADOPTION AND DRIVE SUBSTANTIAL MARKET EXPANSION 71 FIGURE 14 STRONG BIOTECHNOLOGY ADOPTION ACROSS MAJOR AGRICULTURAL ECONOMIES TO PROPEL REGIONAL GROWTH, WITH ASIA PACIFIC AND EUROPE EMERGING AS SIGNIFICANT FUTURE EXPANSION CENTERS 72 FIGURE 15 EUROPE’S BIOTECHNOLOGY DEMAND TO INCREASE DUE TO SUSTAINABILITY MANDATES, CROP PROTECTION INNOVATIONS, AND GROWING RELIANCE ON SOIL ENHANCEMENT AND STRESS-TOLERANCE SOLUTIONS 73 FIGURE 16 DIVERSE REGIONAL INVESTMENTS IN PLANT, ANIMAL, AND MICROBIAL TECHNOLOGIES TO SHAPE GLOBAL MARKET DISTRIBUTION AND STRENGTHEN AGRICULTURAL BIOTECHNOLOGY CAPABILITIES WORLDWIDE 74 FIGURE 17 RAPID PROGRESS IN FERMENTATION, METAGENOMICS, MOLECULAR SELECTION, AND SYNTHETIC BIOLOGY TO SUPPORT HIGH-GROWTH MICROBIAL BIOTECHNOLOGY APPLICATIONS 75 FIGURE 18 INCREASING FOCUS ON PRODUCTIVITY, DISEASE RESISTANCE, ADVANCED THERAPEUTICS, AND WELFARE SOLUTIONS TO BROADEN ANIMAL BIOTECHNOLOGY ADOPTION 75 FIGURE 19 PLANT BIOTECHNOLOGY GROWTH DRIVEN BY INNOVATIONS ENHANCING YIELD, PROTECTION, RESILIENCE, AND NUTRITIONAL QUALITY 76 FIGURE 20 AGRICULTURE BIOTECHNOLOGY MARKET DYNAMICS 78 FIGURE 21 ADOPTION OF GEN AI IN AGRICULTURE BIOTECHNOLOGY 84 FIGURE 22 PORTER’S FIVE FORCES ANALYSIS: AGRICULTURE BIOTECHNOLOGY MARKET 88 FIGURE 23 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION) 90 FIGURE 24 GDP GROWTH, 2016–2023 (USD TRILLION) 91 FIGURE 25 COMPREHENSIVE SUPPLY CHAIN STRUCTURE OF AGRICULTURE BIOTECHNOLOGY MARKET DRIVEN BY CLIMATE-SMART TECHNOLOGIES AND POLICY ALIGNMENT 92 FIGURE 26 AGRICULTURE BIOTECHNOLOGY MARKET: VALUE CHAIN 93 FIGURE 27 AGRICULTURE BIOTECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 93 FIGURE 28 EXPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 100 FIGURE 29 IMPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 101 FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 105 FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION) 105 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE 112 FIGURE 33 KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE 113 FIGURE 34 COMMERCIAL DEPLOYMENT & FUTURE ECOSYSTEM (2032–2035) 118 FIGURE 35 NUMBER OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024 119 FIGURE 36 REGIONAL ANALYSIS OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024 120 FIGURE 37 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2025 VS. 2030 (USD MILLION) 138 FIGURE 38 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 145 FIGURE 39 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 151 FIGURE 40 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 154 FIGURE 41 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 160 FIGURE 42 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 163 FIGURE 43 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 166 FIGURE 44 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 170 FIGURE 45 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 173 FIGURE 46 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 176 FIGURE 47 INDIA TO BE FASTEST-GROWING COUNTRY IN AGRICULTURE BIOTECHNOLOGY MARKET, 2025–2030 181 FIGURE 48 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT 185 FIGURE 49 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT 245 FIGURE 50 AGRICULTURE PLANT BIOTECHNOLOGY: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION) 329 FIGURE 51 AGRICULTURE ANIMAL BIOTECHNOLOGY: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION) 329 FIGURE 52 AGRICULTURE MICROBIAL BIOTECHNOLOGY: REVENUE ANALYSIS FOR KEY PLAYERS, 2022–2024 (USD BILLION) 330 FIGURE 53 SHARE OF LEADING COMPANIES IN PLANT BIOTECHNOLOGY MARKET, 2024 332 FIGURE 54 SHARE OF LEADING COMPANIES IN ANIMAL BIOTECHNOLOGY MARKET, 2024 333 FIGURE 55 SHARE OF LEADING COMPANIES IN MICROBIAL BIOTECHNOLOGY MARKET, 2024 334 FIGURE 56 BRAND/PRODUCT COMPARISON, BY APPLICATION 335 FIGURE 57 COMPANY VALUATION OF KEY AGRICULTURE BIOTECHNOLOGY VENDORS 337 FIGURE 58 EV/EBITDA OF KEY COMPANIES 337 FIGURE 59 PLANT BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 339 FIGURE 60 PLANT BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT 340 FIGURE 61 ANIMAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 343 FIGURE 62 ANIMAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT 344 FIGURE 63 MICROBIAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 347 FIGURE 64 MICROBIAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT 348 FIGURE 65 BASF SE: COMPANY SNAPSHOT 357 FIGURE 66 BAYER AG: COMPANY SNAPSHOT 363 FIGURE 67 CORTEVA AGRISCIENCE: COMPANY SNAPSHOT 370 FIGURE 68 SYNGENTA: COMPANY SNAPSHOT 378 FIGURE 69 KWS SAAT SE & CO. KGAA: COMPANY SNAPSHOT 389 FIGURE 70 UPL: COMPANY SNAPSHOT 395 FIGURE 71 FMC CORPORATION: COMPANY SNAPSHOT 403 FIGURE 72 SUMITOMO CHEMICAL CO., LTD.: COMPANY SNAPSHOT 409 FIGURE 73 NUFARM: COMPANY SNAPSHOT 414 FIGURE 74 ZOETIS INC.: COMPANY SNAPSHOT 421 FIGURE 75 ELANCO OR ITS AFFILIATES: COMPANY SNAPSHOT 425 FIGURE 76 MERCK & CO., INC.: COMPANY SNAPSHOT 429 FIGURE 77 VIRBAC: COMPANY SNAPSHOT 436 FIGURE 78 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT 440 FIGURE 79 GENUS PLC: COMPANY SNAPSHOT 443 FIGURE 80 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT 450 FIGURE 81 NOVONESIS GROUP: COMPANY SNAPSHOT 458

同分類最新報告（農業）

查看農業全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們